Beyond Aurobindo, other manufacturers of quetiapine include Teva Pharmaceuticals, Mylan, and Dr. Reddy's Laboratories [1][2][3]. These companies produce generic versions of the medication.
What is Quetiapine Used For?
Quetiapine is an atypical antipsychotic medication used to treat several mental health conditions. It is prescribed for schizophrenia in adults and adolescents, bipolar disorder (manic and depressive episodes) in adults and children, and as an add-on treatment for major depressive disorder in adults [4][5].
When Does Quetiapine Go Off Patent?
The original patent protection for quetiapine expired in the United States in 2011 [6]. This patent expiry allowed other pharmaceutical companies to begin manufacturing and marketing generic versions of the drug.
How Does Generic Quetiapine Compare to the Brand Name?
Generic quetiapine is bioequivalent to the brand-name drug, meaning it contains the same active ingredient, dosage form, strength, and route of administration [7]. Regulatory agencies like the U.S. Food and Drug Administration (FDA) require generic drugs to meet the same standards of safety and efficacy as their brand-name counterparts [7]. The primary difference typically lies in the inactive ingredients and cost, with generics usually being less expensive.
Who Else Makes Quetiapine Generics?
In addition to Aurobindo, Teva, Mylan, and Dr. Reddy's, other companies that have been involved in manufacturing generic quetiapine include Torrent Pharmaceuticals, Sun Pharmaceutical Industries, and Apotex [1][2][3]. The availability of generic manufacturers can vary by region and market. For a comprehensive list of manufacturers and patent information, DrugPatentWatch.com can be a useful resource [8].
What Are the Risks of Taking Quetiapine?
Quetiapine can have several side effects, including drowsiness, dizziness, dry mouth, weight gain, and constipation [4]. More serious risks can include movement disorders like tardive dyskinesia, metabolic changes (such as high blood sugar and cholesterol), and an increased risk of stroke or death in elderly patients with dementia-related psychosis [4][5]. It is crucial for patients to discuss potential risks and benefits with their healthcare provider.